How to Choose the Right Protein Expression System: E. coli vs. Mammalian vs. Insect vs. Yeast

Choosing the right expression system is often the single biggest factor determining whether a recombinant protein project succeeds or fails. E. coli, mammalian (HEK293/CHO), insect cell (BEVS), and yeast each have distinct strengths and limitations. This guide helps you match system to protein.

E. coli (Prokaryotic): Fastest and cheapest. Ideal for small, non-glycosylated proteins, antigens, and enzymes. No post-translational modifications (PTMs). Risk of inclusion bodies for complex proteins.

Mammalian (HEK293 / CHO): Native folding, full glycosylation, and disulfide bonding. Required for antibodies, Fc-fusion proteins, and any target where PTMs are critical for function. Higher cost and longer timelines.

Insect Cell / BEVS (Sf9, Hi5): Good balance of eukaryotic PTMs and scalability. Simpler glycosylation than mammalian but adequate for many structural and functional studies. No CO₂ incubator needed.

Yeast (Pichia pastoris / S. cerevisiae): Eukaryotic PTMs with prokaryotic-like scalability and cost. High secretion efficiency. Hyper-glycosylation can be an issue for some targets.

Does the protein need glycosylation? No → E. coli. Yes → next question.

Does it need native mammalian-type glycosylation? Yes → HEK293/CHO. Simpler glycosylation acceptable → BEVS or yeast.

Is it an antibody or Fc-fusion? Yes → Mammalian (XtenCHO for high yield).

Is scalability and low cost critical? Yes → E. coli or yeast.

Prone to inclusion bodies in E. coli? Try MBP/SUMO solubility tags first. If still insoluble → switch to BEVS or mammalian.

Not sure which expression system fits your target protein? Share your sequence and application requirements — AtaGenix scientists will recommend the optimal system within 24 hours.

Response within 24 hours